Seikagaku has a unique business model of supplying products through external partnerships in Japan and overseas in collaboration with pharmaceuticals and medical device sales companies. In this way, it intends to focus and develop its business activities without having an in-house pharmaceuticals sales division.

Pharmaceuticals business

The Pharmaceuticals business is Seikagaku’s core business segment.

As a pioneer and leading company in glycoscience, Seikagaku provides high-quality products globally with its unique technologies and knowledge that has been developed for many decades. 
 

Pharmaceuticals and medical devices

Seikagaku manufactures pharmaceuticals and medical devices with as their main ingredient glycosaminoglycan (GAG) such as hyaluronic acid, which are the structural components of glycoconjugates, and also products based on enzymes that act on GAG. To deliver these products to patients globally, Seikagaku forms partnerships with pharmaceutical companies that have expertise in each market, including Japan.

Through the activities, our partners, in conformance with laws and regulations on pharmaceutical sales, provide appropriate information on product efficacy, safety, quality, and other matters to physicians on a timely basis. Seikagaku’s activities such as sales strategy planning, market analysis, collaborations with academic societies, and product information materials creation are conducted in close cooperation with these partners for promoting market penetration. 

As part of product life cycle management, Seikagaku is implementing product modifications that respond to needs of a changing market. One example is the conversion of the material for syringes used for the joint function improving agent ARTZ, from glass to plastic. Through these efforts, we are adding value of our products.

To accelerate and expand our overseas business, Seikagaku is committed to continuously grow in its current markets, and also develop new markets, by responding to global medical needs with its products.

Product Information

ARTZ Intra-articular injections for improving joint functions

Therapeutic Category Brand Name Generic Name Sales partners
Joint function improving agent ARTZ~{®}25mg Purified Sodium Hyaluronate Kaken Pharmaceutical Co., Ltd.
Joint function improving agent ARTZ Dispo~{®}25mg Purified Sodium Hyaluronate

OPEGAN Series Ophthalmic Surgery Aids

Therapeutic Category Brand Name Generic Name Sales partners
Ophthalmic surgery aid OPEGAN~{®}0.6 Purified Sodium Hyaluronate   Santen Pharmaceutical Co., Ltd.
Ophthalmic surgery aid OPEGAN~{®}1.1 Purified Sodium Hyaluronate  
Ophthalmic surgery aid OPEGAN Hi~{®}0.4 Purified Sodium Hyaluronate  
Ophthalmic surgery aid OPEGAN Hi~{®}0.6   Purified Sodium Hyaluronate  
Ophthalmic surgery aid OPEGAN Hi~{®}0.7 Purified Sodium Hyaluronate  
Ophthalmic surgery aid OPEGAN Hi~{®}0.85   Purified Sodium Hyaluronate  

SHELLGAN Ophthalmic surgery aid

Therapeutic Category Brand Name Generic Name Sales partners
Ophthalmic surgery aid SHELLGAN~{®}0.5 Purified Sodium Hyaluronate/
Chondroitin Sulfate Sodium
Santen Pharmaceutical Co., Ltd.

HERNICORE Treatment for lumbar disc herniation

Therapeutic Category Brand Name Generic Name Sales partners
Treatment for lumbar disc herniation HERNICORE~{®}1.25units for Intradiscal Inj Condoliase Kaken Pharmaceutical Co., Ltd.

MucoUp Surgical aid for endoscopic mucosal resection

Common Name Brand Name Composition Sales partners
Submucosal injection agent for
endoscopic surgery
MucoUp~{®} It contains 80mg Purified
Sodium Hyaluronate defined
in J · P in 20mL vial.  
Boston Scientific Japan K.K.

Overseas expansion of joint function improving agents

Area Country Trade Name Sales partners
NORTH AMERICA U.S.A SUPARTZ FX™ Bioventus LLC
Gel-One~{®} Zimmer, Inc
VISCO-3™
EUROPE Italy SUPARTZ~{®} MDM S.p.A.
Hylink~{®}
Sweden ARTZAL~{®} Nordic Drugs AB
Iceland ARTZAL~{®}
ASIA China 阿尓治~{®} Kunming Baker Norton Pharmaceutical Co., Ltd.
Taiwan 雅節~{®} TCM Biotech International Corp.
利節~{®}